Home » Archive for January, 2012
Archive for January, 2012
The Once-Weekly Treatment for Type 2 Diabetes BYDUREON™ Approved By FDA
Jan. 31 | The U.S. Food and Drug Administration (FDA) has approved BYDUREON (exenatide extended-release for injectable suspension) the first once-weekly treatment for type 2 diabetes. BYDUREON is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated as an...
Brain Feels Hungry If You Lack Sleep
Jan. 30 | A new research from Uppasal University, Sweden, shows that a specific brain region that contributes to a person’s appetite sensation is more activated in response to food images after one night of sleep loss than after one night of normal sleep. Poor...
How Brain Cells Die In Alzheimer’s Disease? A New Study Explores
Jan. 30 | A new study explores on the conventional thinking about how brain cells die in Alzheimer’s disease. This new findings demonstrate a previously unknown mechanism by which the cells die and will help lead researchers in new directions for treating the...
India Gears Up To Tackle Mental Disorders
Jan. 25 | India has clearly signaled the world into joining hands to fight against mental disorders such as depression, anxiety, schizophrenia and bipolar disorders. The depression expected to be the leading cause of disease burden globally by 2030. The World...
Challenges In Pain Therapy Drug Development
Jan. 25 | According to a new Espicom report, evolution in the Pain Therapy Market: Nociceptive and Neuropathic Drug Development, despite a plethora of medications, the pain market remains an area of high unmet need as current therapies are often less than effective...
FDA Seeks Additional Info For Approval Of Dapagliflozin For Type 2 Diabetes
Jan. 25 | Bristol-Myers Squibb Company) and AstraZeneca announced that the U.S. Food and Drug Administration (FDA) has issued a complete response letter regarding the New Drug Application (NDA) for investigational compound dapagliflozin for the treatment of type...
Melanoma Pill By Roche Can Cause Mild Skin Cancer
Jan. 25 | According to a study, which was carried out by a team of researchers from the University of California, Roche and Daiichi Sankyo’s Plexxikon, revealed that Roche Holding’s pill Zelboraf taken frequently by melanoma patients can result in imparting...
FDA Approved BTG Drug To Combat Toxic Cancer Medicine
Jan. 25 | The Food and Drug Administration (FDA) approved the drug Voraxaze to combat the toxic effects of a cancer treatment manufactured by BTG Plc (BGC), a London-based specialty pharmaceutical company. The FDA cleared the medicine to reduce toxic methotrexate...
GLP-1 Hormone Could Help Overweight Reduce Weight
Jan. 20 | According to a study, appetite-curbing hormone found in the gut may help overweight and obese people shed weight, lower blood pressure and reduce cholesterol levels. Known as glucagon-like peptide-1, or GLP-1, the hormone is naturally secreted from the...
.
